Clarity Pharmaceuticals Ltd

Company Profile

• Business description

  Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation products that improve treatment outcomes for people with cancer. Its products use the perfect pairing of copper isotopes, copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy, which deliver a compelling combination of high accuracy and high precision in the treatment of a range of cancers. Its core clinical-stage programs, SAR-bisPSMA, SARTATE and SAR-Bombesin, each contain a different targeting agent that binds to specific receptors that are present on different cancer cells. It operates as one segment Development of Radiopharmaceuticals in Australia and the United States.

• Contact

  4 Cornwallis Street
  National Innovation Centre
  Eveleigh
  SydneyNSW2015
  AUS

  T: +61 292094037

  https://www.claritypharmaceuticals.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  Employees

  100